Practice
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
Amer Sports $1.37 billion IPO
We advised Amer Sports on its IPO and NYSE listing
Nextracker spinoff from Flex
We advised Nextracker on its spinoff
Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
We are advising Roche on the acquisition
Varagon Capital Partners acquisition by Man Group
We are advising Varagon Capital Partners on the transaction
Mizuho Financial Group $2.5 billion senior notes offering
The senior callable fixed-to-fixed reset rate notes are due 2029 and 2034
Vesta $445.6 million U.S. IPO
We advised Vesta on its U.S. IPO and NYSE listing
Cadeler $597 million combination with Eneti
We are advising Cadeler on the transaction
Instant Brands chapter 11 filing and $257.5 million DIP financing
We are advising Instant Brands in connection with the restructuring
Mobileye $1.617 billion secondary offering
We advised Mobileye on the registered secondary offering
Shearman & Sterling merger with Allen & Overy
We are advising Shearman & Sterling on the transaction
Forbion European Acquisition combination with enGene
We are advising Forbion European Acquisition on its de-SPAC transaction
Black Spade Acquisition $23 billion combination with VinFast
We are advising Black Spade on its de-SPAC transaction
Josh Harris acquisition of Washington Commanders
We are advising the partnership led by Josh Harris on the transaction